Clinical Trials for STEMI

The "MyoThrombus" Study

NCT ID: NCT04829825

The "MyoThrombus" study is looking into a condition called left ventricular thrombus, which can happen after a heart attack. This condition can lead to serious problems like strokes and further hea...

TIRANA-ACS: A Prospective Registry Study for the Targeted Investigation of Residual Inflammation After Non-ST/ ST Elevation Acute Coronary Syndrome

NCT ID: NCT07026708

No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track

NCT ID: NCT06966674

This clinical trial is studying a treatment called tirofiban, which is used to help improve blood flow in patients who have suffered a heart attack known as STEMI (ST-segment elevation myocardial i...

Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock

NCT ID: NCT05800951

AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS

NCT ID: NCT06528821

This clinical trial, called AI ECG TIMI, is studying how an advanced artificial intelligence (AI) model can help doctors identify problems with blood flow in the heart of patients experiencing acut...

Remote Ischaemic Conditioning in STEMI Patients in AFRICA

NCT ID: NCT04813159

The RIC-AFRICA trial is studying a treatment called Remote Ischaemic Conditioning (RIC) to see if it can help reduce heart-related problems in patients who have had a heart attack known as STEMI. T...

Empagliflozin for No-reflow Phenomenon in PCI for STEMI

NCT ID: NCT06342141

This clinical trial is studying the effects of a medication called empagliflozin in patients who have experienced a heart attack known as STEMI (ST-segment elevation myocardial infarction). Specifi...

Evaluation of Remnant Cholesterol Levels and Monocyte-to-HDL-cholesterol Ratio As Predictors of Coronary Artery Disease Severity in Patients with Acute Coronary Syndrome

NCT ID: NCT06757777

This clinical trial is looking to understand how certain cholesterol levels in the blood can help predict the severity of heart disease in patients who are experiencing acute coronary syndrome (ACS...

Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI

NCT ID: NCT06678074

This clinical trial is studying a new treatment called IC14 (Atibuclimab) for adults who have experienced a type of heart attack known as STEMI, where there is a significant blockage of blood flow ...

COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable

NCT ID: NCT06763549

Outcomes of Isolated LCx Occlusion

NCT ID: NCT06750328

This clinical trial is looking at how well a specific procedure, called primary PCI (percutaneous coronary intervention), works for patients who have a blockage in a heart artery known as the left ...

A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.

NCT ID: NCT03998319

This clinical trial is studying a new treatment approach for patients who have experienced a heart attack called STEMI, which occurs when a blood clot blocks blood flow to the heart. The researcher...

Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus

NCT ID: NCT05825573

The ARGONAUT trial is studying how well a new type of blood thinner, called Direct Oral Anticoagulants (DOA), works compared to traditional blood thinners known as Vitamin K Antagonists (VKA) in pa...

NLR AND CRP Useful as Cost-Effective Preliminary Prognostic Markers in ST-Elevation Myocardial Infarction

NCT ID: NCT06491667

This clinical trial is studying how two specific blood tests, called the neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein (CRP), can help predict outcomes for patients who have had a hea...

OCT Guided Magmaris RMS in STEMI

NCT ID: NCT03955731

This clinical trial is studying the use of a special type of stent called the Magmaris, which is made from magnesium and is designed to dissolve over time. This study focuses on patients who have e...

Predictors of Thrombus Burden in STEMI Patients and Their Impact on Outcome

NCT ID: NCT06471192

This clinical trial is studying a condition called ST-segment elevation myocardial infarction (STEMI), which is a serious type of heart attack. The researchers want to understand how certain factor...

Effects of PCSK-9 Inhibitor Treatment Prior to Undergoing Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

NCT ID: NCT06364124

This clinical trial is studying the effects of a medication called evolocumab, which lowers cholesterol levels, on patients who have had a type of heart attack known as ST-segment elevation myocard...

Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients

NCT ID: NCT05957887

This clinical trial is studying the effects of a medication called Dapagliflozin on heart recovery in patients who have experienced a specific type of heart attack known as an anterior STEMI. The t...

DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction

NCT ID: NCT05764057

This clinical trial is studying a medication called dapagliflozin to see if it can help prevent changes in the heart that can occur after a heart attack, specifically in patients who have left vent...

Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.

NCT ID: NCT04743245

This clinical trial is studying a new treatment called SSO2 therapy, which delivers a special kind of oxygen directly to the heart for 60 minutes. This therapy is being tested on patients who have ...